E. V. Nadey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
E. V. Nadey has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Елена Владимировна Усачева
Omsk State Medical University
5 shared publications - Inna Viktorovna Druk
Omsk State Medical University
4 shared publications Елена Витальевна Надей
Федеральное государственное бюджетное образовательное учреждение высшего образования «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации
3 shared publications- Alexander A. Semenkin
Omsk State Medical University
2 shared publications - Ekaterina N. Loginova
Omsk State Medical University
2 shared publications - Elena A. Ljaljukova
Omsk State Medical University
2 shared publications
Latest Publications
- 10 November 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (5S)
Empathy spectrum in clinical residents: the role of age, year of study, and specialty
Aim . To evaluate the applicability of the Empathy Components Questionnaire (ECQ) for measuring empathy levels in clinical residents, to identify factors associated with empathy, and to determine prospects for further research. Material and methods . This cross-sectional observational study of 53 clinical residents was conducted using the Russian version of the ECQ. Non-parametric tests, multiple linear regression, and Cronbach’s α were applied. Results . The internal consistency of the total ECQ scale was good (α=0,85). The total score was 84,0 (78,0; 89,0). A following U-shaped age-related dynamic was identified for cognitive and affective abilities: the highest values were observed in the ≤25 age group, and the lowest in the 26-28 age group (p < 0,05). No differences were found regarding the year of residency or the specialty. Regression models did not reach significance (R2 ≤0,09). Conclusion . The study results support the use of the ECQ for assessing empathy in professional medical cohorts. Age is a more informative predictor of empathy level changes than the formal year of residency. The low level of cognitive and affective empathy components in the 26- 28 age group serves as an important practical indicator, highlighting the need to develop and implement psychological and pedagogical support programs specifically for residents of this age. The identified patterns suggest a need for further research into factors influencing residents' empathy, as a sufficient level of empathy is a prerequisite for the highquality performance of professional medical duties.
- 10 November 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (5S)
Empathy spectrum in clinical residents: the role of age, year of study, and specialty
Aim . To evaluate the applicability of the Empathy Components Questionnaire (ECQ) for measuring empathy levels in clinical residents, to identify factors associated with empathy, and to determine prospects for further research. Material and methods . This cross-sectional observational study of 53 clinical residents was conducted using the Russian version of the ECQ. Non-parametric tests, multiple linear regression, and Cronbach’s α were applied. Results . The internal consistency of the total ECQ scale was good (α=0,85). The total score was 84,0 (78,0; 89,0). A following U-shaped age-related dynamic was identified for cognitive and affective abilities: the highest values were observed in the ≤25 age group, and the lowest in the 26-28 age group (p < 0,05). No differences were found regarding the year of residency or the specialty. Regression models did not reach significance (R2 ≤0,09). Conclusion . The study results support the use of the ECQ for assessing empathy in professional medical cohorts. Age is a more informative predictor of empathy level changes than the formal year of residency. The low level of cognitive and affective empathy components in the 26- 28 age group serves as an important practical indicator, highlighting the need to develop and implement psychological and pedagogical support programs specifically for residents of this age. The identified patterns suggest a need for further research into factors influencing residents' empathy, as a sufficient level of empathy is a prerequisite for the highquality performance of professional medical duties.
- Open Access
- 7 November 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 3,p. 226-234
Hepatitis with a high degree of activity and multiple organ lesions on the background of Cytomegalovirus infection
Cytomegalovirus (CMV) is a widespread persistent infection capable of reactivation against the background of immunosuppression with the development of severe multiple organ lesions. Using the example of a clinical case, the article describes the development of an active CMV infection complicated by the formation of an autoimmune syndrome involving the liver (high-grade hepatitis), lungs (pneumonia, pulmonary embolism), peripheral nervous system (polyneuropathy) and joints (arthritis). This observation illustrates a rare variant of the course of a mixed infection, in which the reactivation of a persistent virus triggers a dominant autoimmune process leading to a chronic polysystemic disease with an uncertain prognosis. The case highlights the importance of including CMV in the differential diagnostic range for polysystemic and autoimmune syndromes, especially in patients with signs of immune dysfunction.
- 7 November 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 3,p. 226-234
Open AccessHepatitis with a high degree of activity and multiple organ lesions on the background of Cytomegalovirus infection
Cytomegalovirus (CMV) is a widespread persistent infection capable of reactivation against the background of immunosuppression with the development of severe multiple organ lesions. Using the example of a clinical case, the article describes the development of an active CMV infection complicated by the formation of an autoimmune syndrome involving the liver (high-grade hepatitis), lungs (pneumonia, pulmonary embolism), peripheral nervous system (polyneuropathy) and joints (arthritis). This observation illustrates a rare variant of the course of a mixed infection, in which the reactivation of a persistent virus triggers a dominant autoimmune process leading to a chronic polysystemic disease with an uncertain prognosis. The case highlights the importance of including CMV in the differential diagnostic range for polysystemic and autoimmune syndromes, especially in patients with signs of immune dysfunction.
- Open Access
- 15 March 2024
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 10,p. 77-87
Gastroesophageal reflux disease, obesity, bronchial asthma: simple combination or complex interaction
Gastroesophageal reflux disease (GERD) continues to be one of the most common diseases in primary health care. In recent years, the presence of several diseases in the same patient at the same time has been widely discussed. An increase in persons suffering from several chronic diseases is associated with a deterioration in the quality of life, a high risk of hospitalization and mortality, and taking into account the presence of co/poly/multimorbidity is necessary for decision-making when developing a patient management strategy in primary health care. Studies on GERD, obesity and bronchial asthma have shown that there are common and bidirectional mechanisms in the development of these diseases. And, there are many gaps in understanding these relationships, it is important to identify concomitant diseases, since they can be the cause of resistance to therapy, to form an unfavorable prognosis of their course.
- 15 March 2024
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 10,p. 77-87
Open AccessGastroesophageal reflux disease, obesity, bronchial asthma: simple combination or complex interaction
Gastroesophageal reflux disease (GERD) continues to be one of the most common diseases in primary health care. In recent years, the presence of several diseases in the same patient at the same time has been widely discussed. An increase in persons suffering from several chronic diseases is associated with a deterioration in the quality of life, a high risk of hospitalization and mortality, and taking into account the presence of co/poly/multimorbidity is necessary for decision-making when developing a patient management strategy in primary health care. Studies on GERD, obesity and bronchial asthma have shown that there are common and bidirectional mechanisms in the development of these diseases. And, there are many gaps in understanding these relationships, it is important to identify concomitant diseases, since they can be the cause of resistance to therapy, to form an unfavorable prognosis of their course.
- Open Access
- 25 July 2023
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 3,p. 156-160
Clinical case of giant buschke-levenstein condyloma
The article describes a clinical case of Buschke - Levenstein condyloma. The development of the tumor is associated with a papillomavirus infection against the background of an immunodeficiency condition. The difficulties of identifying a causally significant factor, the complexity of patient management, the risk of an unfavorable outcome of the disease are considered. This clinical example demonstrates the need for a timely examination of men for papillomavirus infection and the search for new therapies against the background of topical and systemic immunostimulants.
- 25 July 2023
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 3,p. 156-160
Open AccessClinical case of giant buschke-levenstein condyloma
The article describes a clinical case of Buschke - Levenstein condyloma. The development of the tumor is associated with a papillomavirus infection against the background of an immunodeficiency condition. The difficulties of identifying a causally significant factor, the complexity of patient management, the risk of an unfavorable outcome of the disease are considered. This clinical example demonstrates the need for a timely examination of men for papillomavirus infection and the search for new therapies against the background of topical and systemic immunostimulants.
- Open Access
- 25 July 2023
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 3,p. 61-68
Videocapsular endoscopy in the diagnosis of gastrointestinal diseases
The increase in the frequency of the use of video capsule endoscopy (VCE) in the study of the gastrointestinal tract, the improvement of this technology over the past decade determine the relevance of describing the advantages of this method over traditional endoscopic methods, as well as the disadvantages of the method and directions of development. VCE is a method in which diseases that were previously detected only posthumously are detected. VCE is more informative than X-ray contrast examination methods or magnetic resonance imaging of the gastrointestinal tract. VCE better detects small neoplasms, which improves the quality of diagnosis and allows you to start timely treatment. VCE is rarely the first choice of imaging method. It is most useful for detecting superficial or hidden lesions and is best used in combination with other endoscopic methods. The cost-effectiveness of this study has yet to be determined. The use of video capsule endoscopy is limited by the high cost of research, but in the coming years, thanks to the development of technologies, the cheaper production process, it will become available to many clinics and patients as a research method.
- 25 July 2023
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 3,p. 61-68
Open AccessVideocapsular endoscopy in the diagnosis of gastrointestinal diseases
The increase in the frequency of the use of video capsule endoscopy (VCE) in the study of the gastrointestinal tract, the improvement of this technology over the past decade determine the relevance of describing the advantages of this method over traditional endoscopic methods, as well as the disadvantages of the method and directions of development. VCE is a method in which diseases that were previously detected only posthumously are detected. VCE is more informative than X-ray contrast examination methods or magnetic resonance imaging of the gastrointestinal tract. VCE better detects small neoplasms, which improves the quality of diagnosis and allows you to start timely treatment. VCE is rarely the first choice of imaging method. It is most useful for detecting superficial or hidden lesions and is best used in combination with other endoscopic methods. The cost-effectiveness of this study has yet to be determined. The use of video capsule endoscopy is limited by the high cost of research, but in the coming years, thanks to the development of technologies, the cheaper production process, it will become available to many clinics and patients as a research method.
- Open Access
- 7 October 2022
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 9,p. 129-139
Basics of immunooncology and immunotherapy in oncology
The purpose of the review is to present an analysis of current literature data on tumor immunology, effector mechanisms of antitumor immunity, and prospects for the development of new immunotherapeutic approaches to cancer treatment. Immunological surveillance is the intellectual basis of the idea of tumor immunology. No one doubts the role of immunological mechanisms in protection against tumors. However, tumor cells have a variety of mechanisms that allow them to avoid the action of immune surveillance factors. Some of these factors are aimed at making it difficult to recognize foreign components in the tumor and trigger immune processes. Other mechanisms prevent the implementation of effector mechanisms. Understanding the mechanisms of immunological escape may suggest immune therapy mechanisms that will be widely applicable to different types of cancer.
- 7 October 2022
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 9,p. 129-139
Open AccessBasics of immunooncology and immunotherapy in oncology
The purpose of the review is to present an analysis of current literature data on tumor immunology, effector mechanisms of antitumor immunity, and prospects for the development of new immunotherapeutic approaches to cancer treatment. Immunological surveillance is the intellectual basis of the idea of tumor immunology. No one doubts the role of immunological mechanisms in protection against tumors. However, tumor cells have a variety of mechanisms that allow them to avoid the action of immune surveillance factors. Some of these factors are aimed at making it difficult to recognize foreign components in the tumor and trigger immune processes. Other mechanisms prevent the implementation of effector mechanisms. Understanding the mechanisms of immunological escape may suggest immune therapy mechanisms that will be widely applicable to different types of cancer.
- Open Access
- 7 October 2022
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 9,p. 116-128
Risk factors of malignancy
Prevention strategies aim to change environmental and lifestyle risk factors that contribute to the development of cancer. Screening detects abnormalities before they become clinically apparent, allowing intervention either before cancer develops or at an early stage when treatment is most likely to be effective. Despite reliable data on factors that reduce the risk of neoplasms, in routine clinical practice, the effectiveness of cancer prevention is still not high enough. This determines the high importance of the topic of this review, which summarizes the current scientific data on risk factors for the development of oncopathology and ways to influence them. Such risk factors as lifestyle, alcohol and tobacco use, physical activity, nutrition and other environmental factors are considered. A large role is given to infections, which is also considered in this review. The article highlights the intake of vitamins and microelements for the purpose of cancer prevention, as well as the influence of certain drugs taken to treat non-oncological diseases on the development of oncopathology. The purpose of the review is to present an analysis of current literature data on the methods of cancer prevention.
- 7 October 2022
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 9,p. 116-128
Open AccessRisk factors of malignancy
Prevention strategies aim to change environmental and lifestyle risk factors that contribute to the development of cancer. Screening detects abnormalities before they become clinically apparent, allowing intervention either before cancer develops or at an early stage when treatment is most likely to be effective. Despite reliable data on factors that reduce the risk of neoplasms, in routine clinical practice, the effectiveness of cancer prevention is still not high enough. This determines the high importance of the topic of this review, which summarizes the current scientific data on risk factors for the development of oncopathology and ways to influence them. Such risk factors as lifestyle, alcohol and tobacco use, physical activity, nutrition and other environmental factors are considered. A large role is given to infections, which is also considered in this review. The article highlights the intake of vitamins and microelements for the purpose of cancer prevention, as well as the influence of certain drugs taken to treat non-oncological diseases on the development of oncopathology. The purpose of the review is to present an analysis of current literature data on the methods of cancer prevention.
- Open Access
- 7 October 2022
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 9,p. 222-228
Targeted therapy in oncology
The aim of the review is to highlight the principle of action, effectiveness and prospects for the development of targeted therapy in the treatment of patients with malignant neoplasms based on recent clinical studies. Thanks to the active study of tumor biology, specific target molecules have been discovered and it has become possible to target tumor cells with targeted drugs. Today, targeted drugs are used in the treatment of malignant tumors of various organs and continue to demonstrate their effectiveness, improve overall survival and progression-free time, compared with previous standards of treatment.
- 7 October 2022
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 9,p. 222-228
Open AccessTargeted therapy in oncology
The aim of the review is to highlight the principle of action, effectiveness and prospects for the development of targeted therapy in the treatment of patients with malignant neoplasms based on recent clinical studies. Thanks to the active study of tumor biology, specific target molecules have been discovered and it has become possible to target tumor cells with targeted drugs. Today, targeted drugs are used in the treatment of malignant tumors of various organs and continue to demonstrate their effectiveness, improve overall survival and progression-free time, compared with previous standards of treatment.
- Open Access
- 17 July 2021
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (4) , 2916
Algorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its Assumption
The paper presents algorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its assumption.
- 17 July 2021
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (4) , 2916
Open AccessAlgorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its Assumption
The paper presents algorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its assumption.